- Home
- CLDX vs DCOM Comparison
CLDX vs DCOM Comparison
Compare CLDX & DCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- DCOM
- Stock Information
- Founded
- CLDX N/A
- DCOM 1864
- Country
- CLDX United States
- DCOM United States
- Employees
- CLDX N/A
- DCOM N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- DCOM Major Banks
- Sector
- CLDX Health Care
- DCOM Finance
- Exchange
- CLDX Nasdaq
- DCOM Nasdaq
- Market Cap
- CLDX 1.4B
- DCOM 1.2B
- IPO Year
- CLDX 2008
- DCOM 1996
- Fundamental
- Price
- CLDX $22.08
- DCOM $30.80
- Analyst Decision
- CLDX Strong Buy
- DCOM Strong Buy
- Analyst Count
- CLDX 9
- DCOM 3
- Target Price
- CLDX $46.13
- DCOM $36.50
- AVG Volume (30 Days)
- CLDX 1.5M
- DCOM 182.4K
- Earning Date
- CLDX 08-07-2025
- DCOM 10-21-2025
- Dividend Yield
- CLDX N/A
- DCOM 3.25%
- EPS Growth
- CLDX N/A
- DCOM N/A
- EPS
- CLDX N/A
- DCOM 0.87
- Revenue
- CLDX $5,790,000.00
- DCOM $314,165,000.00
- Revenue This Year
- CLDX N/A
- DCOM $52.99
- Revenue Next Year
- CLDX N/A
- DCOM $15.71
- P/E Ratio
- CLDX N/A
- DCOM $35.16
- Revenue Growth
- CLDX N/A
- DCOM N/A
- 52 Week Low
- CLDX $14.40
- DCOM $23.25
- 52 Week High
- CLDX $47.00
- DCOM $37.60
- Technical
- Relative Strength Index (RSI)
- CLDX 47.99
- DCOM 67.49
- Support Level
- CLDX $21.34
- DCOM $28.25
- Resistance Level
- CLDX $23.27
- DCOM $31.08
- Average True Range (ATR)
- CLDX 1.54
- DCOM 0.81
- MACD
- CLDX -0.15
- DCOM 0.22
- Stochastic Oscillator
- CLDX 33.75
- DCOM 90.79
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.